Picard Medical / SynCardia to Participate in Voice of the Patient Event During AZ Tech Week

Arizona industry event will highlight patient experience, advanced heart failure care, and the real-world impact of life-sustaining therapies

Apr. 2, 2026 at 5:20am

Got story updates? Submit your updates here. ›

Picard Medical, Inc., the parent company of SynCardia Systems LLC, announced that it will participate in the 'Voice of the Patient' event during AZ Tech Week, a program focused on elevating patient perspectives in healthcare innovation. The event will bring together patients, clinicians, and healthcare leaders to discuss the real-world impact of advanced medical technologies, including the SynCardia Total Artificial Heart.

Why it matters

The 'Voice of the Patient' event aims to give a platform for patients to share their experiences and perspectives on innovative medical technologies, which can help drive further advancements in healthcare. Picard Medical's participation highlights the company's commitment to understanding and addressing the needs of patients with advanced heart failure.

The details

Dr. Francisco Arabia, an internationally recognized leader in heart transplantation and mechanical circulatory support, will represent the SynCardia Total Artificial Heart perspective at the event. He has participated in over 200 SynCardia Total Artificial Heart procedures and will be joined by Amanda Vaji, Manager of the Mechanical Circulatory Support Program at Banner University Medical Center Phoenix, as well as a patient who will share their firsthand experience with SynCardia therapy and recovery from advanced heart failure.

  • The event will take place on Thursday, April 9, 2026, from 1:00 PM to 4:00 PM at the University of Arizona Health Sciences Innovation Forum in Tucson, Arizona.

The players

Picard Medical, Inc.

The parent company of SynCardia Systems LLC, the leader in total artificial heart technology for patients with end-stage heart failure.

SynCardia Systems LLC

The Tucson, Arizona-based company that develops, manufactures, and commercializes the SynCardia Total Artificial Heart, the first artificial heart approved by both the FDA and Health Canada.

Dr. Francisco Arabia

An internationally recognized leader in heart transplantation and mechanical circulatory support, who has participated in over 200 SynCardia Total Artificial Heart procedures.

Amanda Vaji

The Manager of the Mechanical Circulatory Support Program at Banner University Medical Center Phoenix.

Got photos? Submit your photos here. ›

What they’re saying

“Advanced heart failure treatment is not only about technology. It is about patients, families, recovery, and quality of life.”

— Patrick NJ Schnegelsberg, CEO of Picard Medical and SynCardia

What’s next

The 'Voice of the Patient' event is open to the public, and registration is available on the AZBio website.

The takeaway

The 'Voice of the Patient' event during AZ Tech Week provides a valuable platform for patients, clinicians, and healthcare leaders to discuss the real-world impact of innovative medical technologies, such as the SynCardia Total Artificial Heart, and how these advancements can improve the lives of those living with advanced heart failure.